View in EDS HTML Full Text PDF Full Text

Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor.

Saved in:
Bibliographic Details
Title: Inhibition of hyperprogressive cancer disease induced by immune-checkpoint blockade upon co-treatment with meta-tyrosine and p38 pathway inhibitor.
Authors: Montagna, Daniela R.1 (AUTHOR) daniela.r.montagna@gmail.com, Duarte, Alejandra2 (AUTHOR), Chiarella, Paula1 (AUTHOR), Rearte, Bárbara3 (AUTHOR), Bustuoabad, Oscar D.1 (AUTHOR), Vermeulen, Mónica4 (AUTHOR), Ruggiero, Raúl A.1 (AUTHOR)
Source: BMC Cancer. 8/3/2022, Vol. 22 Issue 1, p1-17. 17p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14712407
DOI:10.1186/s12885-022-09941-2